We are pleased to share the following 10 Editor's Choice Articles published in Pharmaceuticals (ISSN: 1424-8247). These papers were selected by our Editor-in-Chief from the most notable papers published in Volume 16, Issues 7‒9. All these papers have garnered a high degree of interest among our readers and have all been well received by researchers.

1. “A Comprehensive Review of Azelaic Acid Pharmacological Properties, Clinical Applications, and Innovative Topical Formulations”
by Andreea-Georgiana Petrovici, Mariachiara Spennato, Ioan Bîtcan, Francisc Péter, Livius Cotarcă, Anamaria Todea and Valentin Laurențiu Ordodi
Pharmaceuticals 2025, 18(9), 1273; https://doi.org/10.3390/ph18091273
Available online: https://www.mdpi.com/1424-8247/18/9/1273

2. “Hawthorn (Crataegus spp.) Clinically Significantly Reduces Blood Pressure in Hypertension: A Meta-Analysis of Randomized Placebo-Controlled Clinical Trials”
by Zsóka Szikora, Rebeka Olga Mátyus, Bettina Vargáné Szabó, Dezső Csupor and Barbara Tóth
Pharmaceuticals 2025, 18(7), 1027; https://doi.org/10.3390/ph18071027
Available online: https://www.mdpi.com/1424-8247/18/7/1027

3. “Novel Strategies for the Formulation of Poorly Water-Soluble Drug Substances by Different Physical Modification Strategies with a Focus on Peroral Applications”
by Julian Quodbach, Eduard Preis, Frank Karkossa, Judith Winck, Jan Henrik Finke and Denise Steiner
Pharmaceuticals 2025, 18(8), 1089; https://doi.org/10.3390/ph18081089
Available online: https://www.mdpi.com/1424-8247/18/8/1089

4. “Artificial Intelligence in Small-Molecule Drug Discovery: A Critical Review of Methods, Applications, and Real-World Outcomes”
by Sarfaraz K. Niazi
Pharmaceuticals 2025, 18(9), 1271; https://doi.org/10.3390/ph18091271
Available online: https://www.mdpi.com/1424-8247/18/9/1271

5. “Dopamine Partial Agonists in Pregnancy and Lactation: A Systematic Review”
by Alexia Koukopoulos, Delfina Janiri, Miriam Milintenda, Sara Barbonetti, Georgios D. Kotzalidis, Tommaso Callovini, Lorenzo Moccia, Silvia Montanari, Marianna Mazza, Lucio Rinaldi et al.
Pharmaceuticals 2025, 18(7), 1010; https://doi.org/10.3390/ph18071010
Available online: https://www.mdpi.com/1424-8247/18/7/1010

6. “Combination Strategies with HSP90 Inhibitors in Cancer Therapy: Mechanisms, Challenges, and Future Perspectives”
by Yeongbeom Kim, Su Yeon Lim, Hyun-Ouk Kim, Suk-Jin Ha, Jeong-Ann Park, Young-Wook Won, Sehyun Chae and Kwang Suk Lim
Pharmaceuticals 2025, 18(8), 1083; https://doi.org/10.3390/ph18081083
Available online: https://www.mdpi.com/1424-8247/18/8/1083

7. “Stem Cells and Organoids: A Paradigm Shift in Preclinical Models Toward Personalized Medicine”
by Eleanor Luce and Jean-Charles Duclos-Vallee
Pharmaceuticals 2025, 18(7), 992; https://doi.org/10.3390/ph18070992
Available online: https://www.mdpi.com/1424-8247/18/7/992

8. “Development of Orally Disintegrating Tablets of Standardized Rhodiola rosea Extract”
by Oxana Brante, Rihards Talivaldis Bagons, Santa Niedra, Austris Mazurs, Baiba Mauriņa, Jurga Bernatoniene and Konstantins Logviss
Pharmaceuticals 2025, 18(9), 1328; https://doi.org/10.3390/ph18091328
Available online: https://www.mdpi.com/1424-8247/18/9/1328

9. “Towards a Consensus for the Analysis and Exchange of TFA as a Counterion in Synthetic Peptides and Its Influence on Membrane Permeation”
by Vanessa Erckes, Alessandro Streuli, Laura Chamera Rendueles, Stefanie Dorothea Krämer and Christian Steuer
Pharmaceuticals 2025, 18(8), 1163; https://doi.org/10.3390/ph18081163
Available online: https://www.mdpi.com/1424-8247/18/8/1163

10. “Towards Dual-Tracer SPECT for Prostate Cancer Imaging Using [99mTc]Tc-PSMA-I&S and [111In]In-RM2”
by Carolina Giammei, Theresa Balber, Veronika Felber, Thomas Dillinger, Jens Cardinale, Marie R. Brandt, Anna Stingeder, Markus Mitterhauser, Gerda Egger and Thomas L. Mindt
Pharmaceuticals 2025, 18(7), 1002; https://doi.org/10.3390/ph18071002
Available online: https://www.mdpi.com/1424-8247/18/7/1002

We would like to thank all the research groups behind these exceptional papers for their contributions to Pharmaceuticals and would appreciate it if you could circulate this news among your colleagues or through your network.

If you want to learn more about our Editor’s Choice Articles, please click here.